7 July 2016 - Over the next year, the World Health Organization wants to develop a fair pricing model for pharmaceuticals.

Toward that end, the agency plans to convene governments, patient groups, and drug makers to fashion the notion into something realistic. The trick is to find the right balance between access to affordable medicines and enticing companies to develop new and improved medicines, while also ensuring lower-cost generics remain available.

Pharmalot spoke with Suzanne Hill, the WHO Director of Essential Medicines and Health Products, about how the agency hopes to get this done.

VIew Pharmalot interview with Sue Hill